Pharmaceutical and Biotechnology

We understand the pressures that pharmaceutical and biotechnology companies face when acquiring, developing and introducing new products or technologies— and working with investors. There is no time or money to waste, because the window of opportunity is always shrinking.

To help you capitalize on those opportunities, TCG brings its extensive experience with all the different functions and complexities of today’s fast moving industry. For virtually every pharmaceutical and biotechnology market niche, we quickly grasp the value of the opportunity in context with the specific market forces that will ultimately shape its international potential. Then we translate that potential into reality.

We can help you with:

• Business development and licensing
• Opportunity Assessment and valuation of products and technology
• Pre-launch planning, pricing, sales forecasts and market launch
• Post-launch brand planning, marketing and sales strategy
• Life cycle management and generic defense

Most technology companies fail because they run out of money before they get to a product. This TCG White Paper by Dr. Robert Keefer shows, what should be considered to avoid this.

"Commercialization is all part of brand management, how you build a brand. The companies who specialize in this may prove very helpful" says Dr. Robert Keefer. Read Companies Supporting Other Companies from The State of Life Sciences in North Carolina (Supplement) in The Scientist. To view the full article, click on The Scientist, April 2007.